Baird R W lowered shares of Carisma Therapeutics (NASDAQ:CARM – Free Report) from a strong-buy rating to a hold rating in a research report released on Thursday,Zacks.com reports. CARM has been the ...
Carisma Therapeutics, Inc. (NASDAQ:CARM – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the seven ratings firms that are presently covering the firm, Marketbeat.com ...
Carm Basile is stepping down at the end of this year after more than 43 years with the authority. The agency named Michael Collins, vice president of finance and administration, as interim CEO.
Carm Basile moved from Springfield, MA to Albany in 1981 to take a job with the Capital District Transportation Authority as a transportation planner. He made some lateral moves within the company ...